"Survival Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
Descriptor ID |
D016019
|
MeSH Number(s) |
E05.318.740.998 N05.715.360.750.795 N06.850.520.830.998
|
Concept/Terms |
Survival Analysis- Survival Analysis
- Analysis, Survival
- Analyses, Survival
- Survival Analyses
|
Below are MeSH descriptors whose meaning is more general than "Survival Analysis".
Below are MeSH descriptors whose meaning is more specific than "Survival Analysis".
This graph shows the total number of publications written about "Survival Analysis" by people in this website by year, and whether "Survival Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 0 | 10 | 10 |
1994 | 0 | 11 | 11 |
1995 | 2 | 13 | 15 |
1996 | 1 | 15 | 16 |
1997 | 1 | 13 | 14 |
1998 | 0 | 16 | 16 |
1999 | 0 | 26 | 26 |
2000 | 1 | 29 | 30 |
2001 | 0 | 32 | 32 |
2002 | 1 | 32 | 33 |
2003 | 0 | 47 | 47 |
2004 | 0 | 53 | 53 |
2005 | 1 | 46 | 47 |
2006 | 0 | 58 | 58 |
2007 | 0 | 51 | 51 |
2008 | 2 | 47 | 49 |
2009 | 0 | 47 | 47 |
2010 | 1 | 44 | 45 |
2011 | 2 | 42 | 44 |
2012 | 0 | 42 | 42 |
2013 | 0 | 29 | 29 |
2014 | 0 | 42 | 42 |
2015 | 0 | 34 | 34 |
2016 | 1 | 41 | 42 |
2017 | 3 | 58 | 61 |
2018 | 3 | 46 | 49 |
2019 | 0 | 43 | 43 |
2020 | 0 | 32 | 32 |
2021 | 1 | 26 | 27 |
2022 | 1 | 4 | 5 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Survival Analysis" by people in Profiles.
-
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma. N Engl J Med. 2023 Jul 13; 389(2):148-157.
-
Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation. Blood Adv. 2022 11 22; 6(22):5898-5907.
-
Computational Analysis of High-Dimensional DNA Methylation Data for Cancer Prognosis. J Comput Biol. 2022 08; 29(8):769-781.
-
Multicenter Development and Validation of a Model for Predicting Retention in Care Among People with HIV. AIDS Behav. 2022 Oct; 26(10):3279-3288.
-
Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2. Nat Commun. 2022 01 20; 13(1):405.
-
Nonparametric inference in the accelerated failure time model using restricted means. Lifetime Data Anal. 2022 01; 28(1):23-39.
-
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation. Br J Haematol. 2021 12; 195(5):757-763.
-
Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia. Cancer Med. 2021 11; 10(21):7551-7560.
-
The association of phosphodiesterase-5 inhibitors with the biochemical recurrence-free and overall survival of patients with prostate cancer following radical prostatectomy. Urol Oncol. 2022 02; 40(2):57.e1-57.e7.
-
SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk. 2021 11; 21(11):725-733.